Siegel JS
Center for Psychedelic Medicine, Department of Psychiatry, NYU Grossman School of Medicine, New York, New York.
ArticlePsychedelics
Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History.
ArticlePsilocybin
Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.
ArticlePsychedelics
The science of psychedelic medicine.
ArticlePsychedelics
Trends in Hallucinogen-Related Emergency Department and Hospital Admissions, 2016 to 2023.
ArticlePsilocybin
Provider perspectives on challenges in treatment during psychedelic therapy.
ArticlePsilocybin
Psychedelic 5-HT<sub>2A</sub> receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.
ArticlePsychedelics
Psychedelic Therapies: One Drug, Multiple Treatments Reply to Modesto-Lowe et al.
ArticlePsilocybin
Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.
ArticlePsilocybin
Psilocybin's acute and persistent brain effects: a precision imaging drug trial.
ArticlePsilocybin
The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.
ArticlePsilocybin
Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.
ArticlePsilocybin
Psilocybin desynchronizes the human brain.
PreprintPsilocybin
Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.
PreprintPsilocybin
Psilocybin desynchronizes brain networks
ArticleKetamine
Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.
ArticlePsilocybin